Canada markets closed
  • S&P/TSX

    21,216.15
    +3.76 (+0.02%)
     
  • S&P 500

    4,544.90
    -4.88 (-0.11%)
     
  • DOW

    35,677.02
    +73.94 (+0.21%)
     
  • CAD/USD

    0.8091
    +0.0007 (+0.09%)
     
  • CRUDE OIL

    83.98
    +1.48 (+1.79%)
     
  • BTC-CAD

    75,430.06
    -501.14 (-0.66%)
     
  • CMC Crypto 200

    1,453.34
    -49.69 (-3.31%)
     
  • GOLD FUTURES

    1,793.10
    +11.20 (+0.63%)
     
  • RUSSELL 2000

    2,291.27
    -4.92 (-0.21%)
     
  • 10-Yr Bond

    1.6550
    -0.0210 (-1.25%)
     
  • NASDAQ

    15,090.20
    -125.50 (-0.82%)
     
  • VOLATILITY

    15.43
    +0.42 (+2.80%)
     
  • FTSE

    7,204.55
    +14.25 (+0.20%)
     
  • NIKKEI 225

    28,804.85
    +96.27 (+0.34%)
     
  • CAD/EUR

    0.6942
    -0.0010 (-0.14%)
     

AscellaHealth CEO, Dea Belazi Offers Insights on Digital Health Advances and Improvements to the Patient Experience, as Part of SIIA’s 41st National Educational Conference & Expo

·2 min read

BERWYN, Pa., September 28, 2021--(BUSINESS WIRE)--AscellaHealth, a global specialty pharmacy and healthcare solutions company, announces that Dea Belazi, president and CEO, AscellaHealth, joins industry visionaries on a live panel presentation "Transforming Employee Health Care Experience Through Digital Health Advancements (LIVE)," at SIIA’s 41st Annual National Educational Conference & EXPO, 1:30 p.m. - 2:45 p.m. (CDT), Oct. 4. Attendees will learn about the most attractive digital strategies, as panelists share their perspectives on how digital solutions and patient engagement strategies impact the management of complex and/or chronic conditions and rare or orphan diseases, the importance of digital solutions for medication adherence and compliance and how employers can support telehealth utilization among employees.

"Technology advancements are positively impacting the clinical outcomes of specialty patients making compliance and persistency tools more efficient and user-friendly, with self-insured employers serving as the testing grounds to facilitate the next generation of digital health strategies," says Belazi. "This educational discussion offers insights on emerging digital health advancements and how self-insured employers should structure their group health plans to ensure that their employees will be able to enjoy a truly improved patient experience."

"This SIIA annual meeting gives AscellaHealth a platform to help all specialty pharmacy stakeholders improve every aspect of care including enhanced clinical outcomes for patients and cost savings for payers," says Belazi, who is joined by Michael Gorton, CEO, Recuro Health, and founder of Teladoc; Jeff Dobro, M.D., FACR, chief innovation officer, Transcarent; and Chris Michalak, CEO, Virgin Pulse. "As AscellaHealth emphasizes its focus on specialty pharmacy solutions, our entire team is committed to patient-centric care. We support payers in their quest to reduce costs for expensive Rx therapies, improve the patient journey via customized clinical programs and positively impact costs by managing the specialty pharmacy spend."

About AscellaHealth LLC

AscellaHealth is a global Specialty Pharmacy and Healthcare services organization serving payers, providers, life sciences and patients, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and medical management services. An Inc. 5000 2021 winner, AscellaHealth’s unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or gene and cell therapies. Visit www.AscellaHealth.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210928005417/en/

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting